Maze Therapeutics, Inc. financial data

Symbol
MAZE on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1431% %
Debt-to-equity 27% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,119,444 shares
Common Stock, Shares, Outstanding 48,076,885 shares
Common Stock, Value, Issued $48,000 USD
Weighted Average Number of Shares Outstanding, Basic 45,779,577 shares 1795%
Weighted Average Number of Shares Outstanding, Diluted 45,779,577 shares 1795%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD -100%
Research and Development Expense $25,190,000 USD 27%
General and Administrative Expense $7,775,000 USD 13%
Operating Income (Loss) $32,965,000 USD -36%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $30,087,000 USD -20%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $30,087,000 USD -22%
Earnings Per Share, Basic -0.66 USD/shares 94%
Earnings Per Share, Diluted -0.66 USD/shares 94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $316,773,000 USD 112%
Marketable Securities, Current $67,162,000 USD
Cash, Cash Equivalents, and Short-term Investments $383,900,000 USD
Assets, Current $391,302,000 USD
Property, Plant and Equipment, Net $5,538,000 USD
Operating Lease, Right-of-Use Asset $20,920,000 USD
Other Assets, Noncurrent $3,209,000 USD
Assets $422,058,000 USD
Accounts Payable, Current $2,918,000 USD
Employee-related Liabilities, Current $8,186,000 USD
Liabilities, Current $22,112,000 USD
Operating Lease, Liability, Noncurrent $19,419,000 USD
Other Liabilities, Noncurrent $1,091,000 USD
Liabilities $42,622,000 USD
Retained Earnings (Accumulated Deficit) $454,979,000 USD
Stockholders' Equity Attributable to Parent $379,436,000 USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $379,436,000 USD
Liabilities and Equity $422,058,000 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $29,516,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $127,378,000 USD 418%
Net Cash Provided by (Used in) Investing Activities $299,000 USD -7.2%
Common Stock, Shares Authorized 500,000,000 shares
Common Stock, Shares, Issued 48,076,885 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $317,862,000 USD 111%
Depreciation $684,000 USD -28%
Payments to Acquire Property, Plant, and Equipment $299,000 USD 7.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $30,018,000 USD -21%
Operating Lease, Liability, Current $4,764,000 USD
Preferred Stock, Shares Authorized 10,000,000 shares
Additional Paid in Capital $834,298,000 USD
Share-based Payment Arrangement, Expense $3,864,000 USD 65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares